SPY331.87+1.81 0.55%
DIA271.00+2.59 0.96%
IXIC10,983.79+42.63 0.39%

Cantor Fitzgerald Reiterates Overweight on Zosano Pharma, Lowers Price Target to $6

Cantor Fitzgerald reiterates Zosano Pharma (NASDAQ:ZSAN) with a Overweight and lowers the price target from $12 to $6.

Benzinga · -

Cantor Fitzgerald reiterates Zosano Pharma (NASDAQ:ZSAN) with a Overweight and lowers the price target from $12 to $6.